Table 1.
Patients’ characteristics.
| Characteristics | Patients (n = 52) | % |
|---|---|---|
| Age, years | Median 48 (range, 30–69) | |
| Sex | ||
| Female | 15 | 28.8 |
| Male | 37 | 71.2 |
| ECOG performance status | ||
| 0 | 11 | 21.2 |
| 1 | 26 | 50.0 |
| 2 | 15 | 28.8 |
| Tumor involved site | ||
| Nasopharyngeal | 6 | 11.5 |
| Lymph node | 14 | 26.9 |
| Lung | 29 | 55.8 |
| Liver | 13 | 25.0 |
| Bone | 8 | 15.4 |
| Number of involved sites | ||
| 1 | 30 | 57.7 |
| 2 | 15 | 28.8 |
| 3 | 7 | 13.5 |
| Initially received platinum-based chemotherapy for recurrence/metastases | ||
| Cisplatin + 5-fluorouracil | 7 | 13.5 |
| Cisplatin + gemcitabine | 21 | 40.4 |
| Cisplatin + docetaxel | 16 | 30.8 |
| Cisplatin + paclitaxel | 10 | 19.2 |
| Carboplatin + paclitaxel | 14 | 26.9 |
| Number of chemotherapy regimens received | ||
| One | 17 | 32.7 |
| Two | 25 | 48.1 |
| ⩾Three | 10 | 19.2 |
ECOG, Eastern Cooperative Oncology Group.